Soleno Therapeutics Deal History & Licensing Activity
Soleno Therapeutics is a life sciences. Over the past three years, Soleno Therapeutics has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (2 deals).
Deals (12mo)
0
Active Trials
0
Top Modality
Small Molecules
Focus Area
Mega Deals
Soleno Therapeutics Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Soleno Therapeutics in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Vykat XR | Neurocrine Biosciences | Small Molecules | Unknown | acquisition | Apr 2026 |
Soleno Therapeutics Pipeline Focus
Therapeutic areas and modalities where Soleno Therapeutics is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Soleno Therapeutics's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Soleno Therapeutics Licensing & Deal Activity
Soleno Therapeutics is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Soleno Therapeutics ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Soleno Therapeutics include Mega Deals (2 deals and trials). In terms of modality, Soleno Therapeutics has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Soleno Therapeutics and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Soleno Therapeutics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.